Xeris Biopharma Holdings Inc. buy Piper Sandler
Start price
10.11.23
/
50%
€1.60
Target price
10.11.24
€3.74
Performance (%)
9.50%
Price
03.05.24
€1.75
Summary
This prediction is currently active. With a performance of 9.50%, the BUY prediction by Piper_Sandler for Xeris Biopharma Holdings Inc. is trending in the right direction. This prediction currently runs until 10.11.24. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | 7.419% | 7.419% |
| iShares Core DAX® | -0.922% | -1.078% |
| iShares Nasdaq 100 | 0.371% | -0.556% |
| iShares Nikkei 225® | 2.224% | -2.825% |
| iShares S&P 500 | -0.026% | -0.788% |
Comments by Piper_Sandler for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target lowered by analysts at Piper Sandler from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for XERS provided by MarketBeat